AzTrials
AzTrials

Low Back PainNCT05467592

Central Sensitization in Patients Seeking Outpatient Physical Therapy Services

An observational study of Low Back Pain and Knee Osteoarthritis, run by University of Kansas Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is an observational study to examine presence of CS in patients with knee osteoarthritis (OA), chronic LBP (CLBP), and chronic neck pain (CNP) seeking outpatient physical therapy (PT) services. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Low Back Pain, Knee Osteoarthritis, Neck Pain
What is being tested?
Standard Physical Therapy care
Type of treatment
Injection or infusion
How many people
77 participants
Where
1 siteUnited States
Study dates
6 Jun 2022to 22 Jan 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: All subjects over the age of 18 with knee OA, CLBP, and CNP will be asked to consent.

Who may be able to join

  • Diagnosis of knee, neck, or back pain
  • Chronic pain as defined pain > 3 months
  • Able to read and understand English

Who cannot join

  • Pregnancy
  • Pain less than 3 months

Trial locations and contacts

1 site in 1 country.

United States1 site
  • LifeWorks

    Shawnee Mission, Kansas, 66226

Other trials in United States

About this study

This is an observational study to examine presence of CS in patients with knee osteoarthritis (OA), chronic LBP (CLBP), and chronic neck pain (CNP) seeking outpatient physical therapy (PT) services. The study will also examine if outcomes differ between patients with CS and patients without CS symptoms with standard PT interventions.

Read the detailed description

Central Sensitization (CS), defined as augmented pain processing, is common in subgroup of nearly all chronic pain conditions, including fibromyalgia, CLBP, OA, and chronic tension headache. However, current studies of CS are primarily limited to research settings, lacking the knowledge about prevalence of CS and rehabilitation outcomes in usual clinical care.

Practicing clinicians do not routinely assess for CS symptoms. Without proper screening for CS, and lack of knowledge of varying levels of nervous system involvement contributing to pain, clinicians are unable to fully identify the depth of the mechanisms and therefore unable to fully determine the best treatment strategies. This observational study addresses this gap in knowledge by screening patients for CS symptoms.

Being tested
Standard Physical Therapy care
Medical subject headings
Low Back Pain, Osteoarthritis, Knee, Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard Physical Therapy careOther

    Also called Physical Therapy

    All therapy will be given as it would have routinely been administered in the clinic. Standard care for all patients includes physical therapy and chiropractic treatment at each visit. There is a nurse practitioner on site. If necessary, patients can receive trigger point injections to the musculature around the back and neck, platelet rich plasma, or headache injections by the nurse practitioner. These interventions vary on a case by case basis. Involvement in the study will not impact the patients plan of care. We will collect this information as confounders and factor into statistical analysis.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of patients with knee OA, CLBP, and CNP presenting with CS symptoms.

    Percentage of patients with knee OA, CLBP, and CNP presenting with CS symptoms.

    Measured: Through study completion, up to 16 weeks

  2. 2011 Fibromyalgia (FM) survey

    A standard questionnaire for centralized pain. Scores 3-6 in widespread pain index and 9 or greater in symptom severity suggest widespread pain

    Measured: Through study completion, up to 16 weeks

  3. Beck Anxiety Inventory

    A standard questionnaire with 21 questions. Scores 0-21=low anxiety, scores 22-35=moderate anxiety and scores 36 and above=potentially concerning level of anxiety

    Measured: Through study completion, up to 16 weeks

  4. Pittsburg sleep scale

    A standard questionnaire to examine sleep problems. A total of 5 scores or greater indicate poor sleep quality

    Measured: Through study completion, up to 16 weeks

  5. Fear Avoidance Questionnaire

    A standard questionnaire to examine fear related to work and physical activities.

    Measured: Through study completion, up to 16 weeks

  6. Lower Extremity Functional Scale (LEFS) for patients with knee OA

    LEFS is a 20-question survey about the participant's ability to perform everyday tasks.

    Measured: Through study completion, up to 16 weeks

  7. Neck Disability Index (NDI) for patients with CNP

    NDI is a 10-question survey in which participants check a box corresponding to how their neck pain impacts their activities of daily living.

    Measured: Through study completion, up to 16 weeks

  8. Oswestry Disability Index (ODI) for patients with CLBP

    ODI is a 10-question survey in which participants check a box corresponding to how their low back pain impacts their activities of daily living.

    Measured: Through study completion, up to 16 weeks

  9. Physical Therapy examination data

    Routine PT subjective and objective examination data that includes history taking, range of motion, muscle testing, and neurological exam if necessary

    Measured: Through study completion, up to 16 weeks

  10. Functional Exam as part of routine primary PT

    Routine PT functional assessment includes gait, sit-to-stand, stair climbing, and squats

    Measured: Through study completion, up to 16 weeks

  11. Neck flexor muscle performance

    Strength and endurance. Strength will be tested manually with 0-5 MMT standard grading scale or with use of dynamometer for strength and endurance performance of individual muscles.

    Measured: Through study completion, up to 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2022
  2. Study start6 Jun 2022
  3. Primary completion22 Jan 2024
  4. Study completion22 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
77 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05467592
Sponsor's protocol ID
STUDY00148639
Status last verified
May 2025
First submitted
16 May 2022
Last updated
20 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Low Back Pain and Knee Osteoarthritis, run by University of Kansas Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of patients with knee OA, CLBP, and CNP presenting with CS symptoms. (time frame: Through study completion, up to 16 weeks). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in